The Introduction Of Biosimilar Monoclonal Antibodies Into Developed Markets- What Are Payers Concerned About?

May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.1160
https://www.valueinhealthjournal.com/article/S1098-3015(13)01231-X/fulltext
Section Title : Muscular-Skeletal Disorders
Section Order : 737
First Page : A229
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01231-X&doi=10.1016/j.jval.2013.03.1160
HEOR Topics :
Tags :
Regions :